MusclePharm Corporation
MSLPQ
$0.00
$0.000.00%
| 03/31/2022 | 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | |
|---|---|---|---|---|---|
| Net Income | -6,803.19% | -340.28% | -680.09% | -789.72% | 256.67% |
| Total Depreciation and Amortization | -57.14% | -13.68% | -20.95% | -32.79% | -41.26% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 766.67% | 40.93% | 169.10% | 134.71% | -52.83% |
| Change in Net Operating Assets | -275.48% | 89.16% | 66.67% | -34.28% | -91.36% |
| Cash from Operations | -3,755.10% | -62.19% | -213.63% | -196.80% | -39.13% |
| Capital Expenditure | -- | -- | 100.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -50.00% | -100.00% | -- | -136.36% |
| Total Debt Issued | 9.41% | 22.56% | 3.42% | 26.77% | 33.13% |
| Total Debt Repaid | 23.04% | -4.23% | 16.84% | -11.77% | -33.70% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 292.23% | 47.31% | 154.61% | 426.44% | -38.58% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 51.17% | -8.61% | -393.75% | -28.74% | -54.38% |
